Drug recall
Blood and Blood Products for Reprocessing
FDA recall event 84667 · Class II, Class III · Vitalant
Key facts
| Event ID | 84667 |
|---|---|
| Recall numbers | B-0252-2020, B-0253-2020 |
| Recalling firm | Vitalant |
| Product type | Biologics |
| Products | Blood and Blood Products for Reprocessing, Red Blood Cells, Leukocytes Reduced |
| Classification | Class II, Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Blood products, for which donor eligibility screening was incorrectly performed, were distributed. |
| Initiation date | Dec 3, 2019 |
| Report date | Jan 29, 2020 |
| Termination date | Jan 21, 2020 |
| City | Rapid City |
| State | SD |
| Country | United States |
| FEI number | 1771468 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: